Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,770.00
Bid: 2,113.00
Ask: 1,708.50
Change: 9.00 (0.51%)
Spread: -404.50 (-19.143%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks rise for fourth day on healthcare bounce

Thu, 28th May 2020 10:19

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Cineworld soars on cash boost, targets July reopening

* Defensive sectors lead late rally in Europe

* Markets ignore U.S.-China tensions for now
(Updates to market close)

By Sruthi Shankar

May 28 (Reuters) - European shares rose for a fourth
straight session on Thursday, as optimism over businesses
returning to work and stimulus for the battered euro zone
economy outweighed rising U.S.-China tensions.

The pan-European STOXX 600 index rose 1.6% to hit
an 11-week high, with healthcare stocks rebounding from
losses earlier this week.

GlaxoSmithKline, the world's largest vaccine maker,
gained 2.1% as it laid out plans to produce 1 billion doses of
vaccine efficacy boosters for COVID-19 shots next year.

Other defensive sectors such as personal & household goods
, telecoms and utilities also rose.

UK cinema operator Cineworld surged 21.4% to the
top of the STOXX 600 after saying it expected to reopen all its
venues in July and had secured additional liquidity.

The STOXX 600 has risen more than 32% from its March lows as
investors hope for a gradual recovery with policymakers
injecting trillions of dollars into the global economy and
drugmakers racing to develop a COVID-19 vaccine.

The mood in Europe has brightened this week on a
750-billion-euro ($826.35 billion) EU plan to prop up the bloc's
virus-hit economies, while hopes are running high the European
Central Bank will further expand its bond purchase programme
next week, possibly by 500 billion euros.

"I think there's a good chance they will expand their...
asset purchase program," Nicola Mai, sovereign credit analyst at
PIMCO told the Reuters Global Markets Forum.

"The current purchase envelope will likely be exhausted
before year end, and the ECB may want to start providing some
more certainty that it remains in play beyond that."

Investors looked past a fresh escalation in Sino-U.S.
tensions after China's parliament approved a decision to move
forward with national security legislation for Hong Kong.

U.S. President Donald Trump has promised to take action over
the move by the end of the week.

"Markets are taking solace from the fact that neither party
seems incentivised to escalate threats economically so far. But
I think there will be a point when markets will be fixated on
U.S.-China tensions," said Brooks Macdonald Asset Management's
Edward Park.

Italian luxury group Salvatore Ferragamo surged
16% after it called back its former chief executive officer to
help weather the COVID-19 storm.

And Scandinavian airline SAS slumped 11.2% after
revealing it was in talks with shareholders to raise funds as
the collapse in travel demand hurt its quarterly results.
(Reporting by Sruthi Shankar in Bengaluru; additional reporting
by Aaron Saldanha and Lisa Mattackal; Editing by Kirsten
Donovan)

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.